AKT1 and Alzheimer disease: Additionally, curcumin has the ability to inhibit Aβ-induced tau hyperphosphorylation through the phosphatase and tensin homolog (PTEN)/Akt/Glycogen synthase kinase-3β (GSK-3β) pathway, showing great potential in improving targeted drug delivery and neuronal function recovery in the treatment of AD.